Covered recipient · General Payments record
ALEXANDRA REESE
General Payments · PY2023–2024
$1,772.24
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,473.98 | 27 |
| Education | $68.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $438.98 | 6 |
| Janssen Scientific Affairs, LLC | $361.95 | 4 |
| ABBVIE INC. | $327.39 | 13 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $133.22 | 1 |
| Mallinckrodt Hospital Products Inc. | $122.09 | 1 |
| E.R. Squibb & Sons, L.L.C. | $83.60 | 1 |
| Janssen Biotech, Inc. | $75.74 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.09 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105932536 | CMS |
| ABBVIE INC. | $23.19 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105932538 | CMS |
| ABBVIE INC. | $9.66 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105932540 | CMS |
| ABBVIE INC. | $106.62 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105932542 | CMS |
| ABBVIE INC. | $11.05 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105932544 | CMS |
| ABBVIE INC. | $9.87 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105932546 | CMS |
| ABBVIE INC. | $13.04 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105932548 | CMS |
| ABBVIE INC. | $31.86 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105932550 | CMS |
| ABBVIE INC. | $28.63 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105932552 | CMS |
| ABBVIE INC. | $6.88 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105932554 | CMS |
| ABBVIE INC. | $30.85 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105932556 | CMS |
| ABBVIE INC. | $27.41 | 11/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105932558 | CMS |
| ABBVIE INC. | $8.24 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105932560 | CMS |
| Amgen Inc. | $124.21 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111686105 | CMS |
| Amgen Inc. | $23.46 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111686103 | CMS |
| Amgen Inc. | $28.11 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111686099 | CMS |
| Amgen Inc. | $125.00 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111686097 | CMS |
| Amgen Inc. | $124.99 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117362485 | CMS |
| Amgen Inc. | $13.21 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111686101 | CMS |
| E.R. Squibb & Sons, L.L.C. | $83.60 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101328398 | CMS |
| Janssen Biotech, Inc. | $6.75 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078486641 | CMS |
| Janssen Biotech, Inc. | $68.99 | 04/24/2024 | Education | Undisputed | 01/23/2026 | 1078486698 | CMS |
| Janssen Scientific Affairs, LLC | $85.15 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078856512 | CMS |
| Janssen Scientific Affairs, LLC | $6.05 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078856516 | CMS |
| Janssen Scientific Affairs, LLC | $142.86 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078856514 | CMS |
| Janssen Scientific Affairs, LLC | $127.89 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078856510 | CMS |
| Mallinckrodt Hospital Products Inc. | $122.09 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145126113 | CMS |
| Novartis Pharmaceuticals Corporation | $133.22 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087311457 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.